Restless legs syndrome: A clinical study in Chilean general population and in uremic patients;Síndrome de piernas inquietas: Estudio clínico en población general adulta y en pacientes urémicos

Revista Medica de Chile

Volumn 129, Issue 2, 2001, Pages 179-186

  Miranda C, Marcelo ^a   Araya D, Fernando ^a   Castillo C, José Luis ^a   Durán S , Cristina ^a   González F, Fernando ^a   Arís T, Luis ^a  

^a NONE

Author keywords

Hemodialysis; Restless legs, Uremia

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILE; FEMALE; HUMAN; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RESTLESS LEGS SYNDROME; SEX DIFFERENCE; UREMIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILE; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RESTLESS LEGS SYNDROME; SEX FACTORS; UREMIA;

EID: 0035258029     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. WALTERS AS. The International Restless Legs Syndrome Study Group.Towards a better definition of the restless legs syndrome. Mov Disord 1995; 10: 634-52.
2. WINKELMANN J. Restless Legs Syndrome (History of Neurology: Seminal citations). Arch Neurol 1999; 56: 1526-7.
3. COLLADO-SEIDEL V, WINKELAMNN J, TRENKWALDER C. Aetiology and Treatment of Restless Legs Syndrome. CNS Drugs 1999; 12: 9-20.
4. EKBOM K. Restless Legs Syndrome. Acta Med Scand 1945; 158: 4-122.
5. COLLADO-SEIDEL V, KOHNEN R, SAMTLEBEN W, HILLEBRAND G, OERTEL W, TRENKWALDER C. Clinical and Biochemical Findings in Uremic Patients With and Without Restless Legs Syndrome. Am J Kidney Dis 1998; 31: 324-8.
6. WINKELMANN J, CHERTOW G, LAZARUS J. Restless Legs syndrome in end-stage renal disease. Am J Kidney Dis 1996; 28: 372-8.
7. ROTHDACH A, TRENKWALDER C, HABERSTOCK J, KEIL U, BERGER K. Prevalence and rik factors of RLS in an elderly population. Neurology 2000; 54: 1064-8.
8. TRENKWALDER C, COLLADO-SEIDEL V, GASSER T, OERTEL W. Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Mov Disord 1996; 11: 389-94.
9. PHILIPS B, YOUNG T, FINN L, ASHER K, HENING W, PURVIS C. Epidemiology of Restless Legs Symptoms in Adults. Arch Int Med 2000; 160: 2137-41
10. SAWLE G. Movement Disorders during Sleep. En Sawle G. Movement Disorders in Clinical Practice. Oxford Isis Medical Media. 1999; 159-65.
11. GIMENEZ ROLDAN S, MATEO M. Restlless Legs Syndrome and Related Movement Disorders. En Tolosa E, Koller W Gershanik O. Eds. Differential Diagnosis and Treatment of Movement Disorders. Boston. Butterworth-Heinemann. 1998; 137-46.
12. WALTERS A, MANDELBAUM D, LEWIN D, KULER S, ENLAND S, MILLER M. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Pediatr Neurol 2000; 22: 182-6.
13. TRENKWALDER C, BUCHER S, OERTEL W, PROECKL D, PLENDL H, PAULUS W. Bereitschaftspotential in idiopathic and symptomatic restless legs syndrome. Electroenceph Clin Neurophysiol 1993; 689: 95-103.
14. ENTEZAN-TAHER M, SINGLETON J, JONES C, MEEKINS G, PETEJAN J, SMITH A. Changes in excitability of motor cortical circuitry in RLS. Neurology 1999; 53: 1201-6.
15. STIASNY K, HAESKE H, MUELLER H, BRAUNE H, OERTEL W. Influence of levodopa on cortical silent period in patients with idiopathic restless legs syndrome. Mov Disord 2000; 15 (suppl 3): 80.
16. BARA-JIMENEZ W, AKSU M, GRAHAM B, SATO S, HALLET M. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 2000; 54: 1609-16.
17. LINDVALL O, BJORKLUND A, AKAGERBERG G. Dopamine-containing neurons in the spinal cord: anatomy and some functional aspects. Ann Neurol 1983; 14: 255-60.
18. TURJANSKI N, LEES A, BROOKS D. Striatal dopaminergic function in restless legs syndrome. 18F-dopa and 11C-raclopride studies. Neurology 1999; 52: 932-7.
19. ROUTINEN H, PARTINEN M, HUBLIN C, BERGMAN J. An F-dopa PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 2000; 54: 502-4.
20. EARLEY C, CONNORS J, ALLEN R. RLS patients have abnormally reduced CSF ferritin compared to normal controls. Neurology 1999; 52 (suppl 2)A111-112.
21. EARLEY C, CONNORS J, BEARD J, MELECKI A, EPSTEIN P, ALLEN R. Abnormalities in CSF concentrations of ferritin and transferrin in RLS. Neurology 2000; 54: 1698-1700.
22. ROGER S, HARRIS D, STEWART J. Possible relation between restless legs and anaemia in renal dialysis patients. Lancet 1991; 337: 1551.
23. TRENKWALDER C, STIASNY K, POLLMACHER T, WETTER J, SCWARZ J, KOHNEN R ET AL. L-dopa therapy of uremic and idiopathic Restless legs Syndrome: a double-blind, crossover trial. Sleep 1995; 18: 681-8.
24. EARLEY C, YAFFEE J, ALLEN R. Randomised, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology 1998; 51: 1599-1602
25. STRANG R. The symptoms of Restless Legs. Med J Aust 1967; 1: 1211-3.
26. MONTPLAISIR J, NICOLAS A, DENESIA R, GOMEZ-MANCILLA. Restless legs syndrome improved by pramipexole. A double-blind randomised trial. Neurology 1999; 52: 938-43.
27. READ D, FEEST T, NASSIM M. Clonazepam: effective treatment for restless legs syndrome in uraemia. BMJ 1981; 283: 885-6.
28. WALTERS A, WAGNER M, HENING W, GRASING K, MILLS R, CHOKROVERTY S ET AL. Successful treatment of idiopathic restless legs syndrome in a randomised double-blind trial of oxycodone versus placebo. Sleep 1993;16:327-32.
29. TELSTAD W, SORENSEN O, LARSEN S. Treatment of restless legs syndrome with carbamazepine: a double-blind study. BMJ 1984; 288: 444-6.
30. ADLER CH. Treatment of restless legs syndrome with gabapentine. Clin Neuropharmacol 1997; 20: 148-151.